“Concept Medical Inc. has developed the first sirolimus coated balloon catheter based on NANOLUTETM Technology. NANOLUTETM Technology is a polymer-free Nano-carrier based drug delivery for programmed drug release and long term drug retention in vessel wall. This technology addresses both cardiovascular disease as well as peripheral disease. This will be a new procedural option for treating stenosis in the coming future as drug elution does not always require stent platform.”
“XtremeTouch Sirolimus Coated PTA balloon catheter is a product of NANOLUTE Technology and it has innovative features such as Lower tip entry profile, Circumferential coating allows homogeneous drug penetration and May become default treatment in SFA and Popliteal/infra Popliteal vessels, as well as in ISR anywhere”
“MagicTouch is First Sirolimus coated PTCA balloon catheter is a product of NANOLUTE Technology. It is indicated for coronary artery disease like in-stent restenosis, Bifurcation lesions and small vessels.”
Concept Medical Inc. (CMI) is establishment of USA with the vision of “Inspiring Innovation”. CMI was founded in year 2008, having the mission of “converting concepts into reality” in the field of drug delivering medical devices industry.